Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Kenmerk
Swollen lymph nodes
Klinische naam: Lymphadenopathy
Enlargement (swelling) of a lymph node.
Samenvatting
- Ook bekend als
- Lymph node hyperplasia
Swollen lymph nodesHP:0002716
Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Read the genes linked to Swollen lymph nodes, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen236 genen gekoppeld aan Swollen lymph nodes
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Swollen lymph nodes voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| CASP10caspase 10 | Altijd | In 2 aandoeningen |
| CASP8caspase 8 | Altijd | In 1 aandoening |
| CD70CD70 molecule | Altijd | In 1 aandoening |
| CTNNBL1catenin beta like 1 | Altijd | In 1 aandoening |
| CYBC1cytochrome b-245 chaperone 1 | Altijd | In 1 aandoening |
| HMOX1heme oxygenase 1 | Altijd | In 1 aandoening |
| IKZF2IKAROS family zinc finger 2 | Altijd | In 1 aandoening |
| IL2RAinterleukin 2 receptor subunit alpha | Altijd | In 2 aandoeningen |
| IL6STinterleukin 6 cytokine family signal transducer | Altijd | In 1 aandoening |
| IRF8interferon regulatory factor 8 | Altijd | In 2 aandoeningen |
| ITKIL2 inducible T cell kinase | Altijd | In 1 aandoening |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Altijd | In 1 aandoening |
| LATlinker for activation of T cells | Altijd | In 1 aandoening |
| MAGT1magnesium transporter 1 | Altijd | In 1 aandoening |
| MCTS1MCTS1 re-initiation and release factor | Altijd | In 1 aandoening |
| NBNnibrin | Altijd | In 1 aandoening |
| NCKAP1LNCK associated protein 1 like | Altijd | In 1 aandoening |
| NLRP3NLR family pyrin domain containing 3 | Altijd | In 3 aandoeningen |
| PLD4phospholipase D family member 4 | Altijd | In 1 aandoening |
| POLD3DNA polymerase delta 3, accessory subunit | Altijd | In 1 aandoening |
| PRKCDprotein kinase C delta | Altijd | In 1 aandoening |
| PSMG2proteasome assembly chaperone 2 | Altijd | In 1 aandoening |
| RASGRP1RAS guanyl releasing protein 1 | Altijd | In 1 aandoening |
| RC3H1ring finger and CCCH-type domains 1 | Altijd | In 1 aandoening |
| SHARPINSHANK associated RH domain interactor | Altijd | In 1 aandoening |
| SLC29A3solute carrier family 29 member 3 | Altijd | In 2 aandoeningen |
| STXBP2syntaxin binding protein 2 | Altijd | In 2 aandoeningen |
| TET2tet methylcytosine dioxygenase 2 | Altijd | In 4 aandoeningen |
| TPP2tripeptidyl peptidase 2 | Altijd | In 2 aandoeningen |
| TRACT cell receptor alpha constant | Altijd | In 1 aandoening |
| TRAF3TNF receptor associated factor 3 | Altijd | In 1 aandoening |
| UNGuracil DNA glycosylase | Altijd | In 1 aandoening |
| ZAP70zeta chain of T cell receptor associated protein kinase 70 | Altijd | In 2 aandoeningen |
| ADAadenosine deaminase | Heel vaak (80–99%) | In 1 aandoening |
| ATMATM serine/threonine kinase | Heel vaak (80–99%) | In 1 aandoening |
| BCL2BCL2 apoptosis regulator | Heel vaak (80–99%) | In 1 aandoening |
| BCL6BCL6 transcription repressor | Heel vaak (80–99%) | In 1 aandoening |
| CCND1cyclin D1 | Heel vaak (80–99%) | In 2 aandoeningen |
| CD28CD28 molecule | Heel vaak (80–99%) | In 2 aandoeningen |
| CHD7chromodomain helicase DNA binding protein 7 | Heel vaak (80–99%) | In 1 aandoening |
Toon nog 196 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| CLCN7Cl-/H+ antiporter 7 | Heel vaak (80–99%) | In 1 aandoening |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Heel vaak (80–99%) | In 5 aandoeningen |
| DCLRE1CDNA cross-link repair 1C | Heel vaak (80–99%) | In 2 aandoeningen |
| EIF2AK4eukaryotic translation initiation factor 2 alpha kinase 4 | Heel vaak (80–99%) | In 1 aandoening |
| EWSR1EWS RNA binding protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| FASFas cell surface death receptor | Heel vaak (80–99%) | In 2 aandoeningen |
| FASLGFas ligand | Heel vaak (80–99%) | In 1 aandoening |
| GINS1GINS complex subunit 1 | Heel vaak (80–99%) | In 1 aandoening |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Heel vaak (80–99%) | In 4 aandoeningen |
| IGHimmunoglobulin heavy locus | Heel vaak (80–99%) | In 3 aandoeningen |
| IL2RGinterleukin 2 receptor subunit gamma | Heel vaak (80–99%) | In 1 aandoening |
| IL7Rinterleukin 7 receptor | Heel vaak (80–99%) | In 3 aandoeningen |
| MVKmevalonate kinase | Heel vaak (80–99%) | In 3 aandoeningen |
| NUDCD3NudC domain containing 3 | Heel vaak (80–99%) | In 1 aandoening |
| OSTM1osteoclastogenesis associated transmembrane protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| PSMB10proteasome 20S subunit beta 10 | Heel vaak (80–99%) | In 1 aandoening |
| RAG1recombination activating 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| RAG2recombination activating 2 | Heel vaak (80–99%) | In 2 aandoeningen |
| RIPK1receptor interacting serine/threonine kinase 1 | Heel vaak (80–99%) | In 1 aandoening |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Heel vaak (80–99%) | In 1 aandoening |
| SNX10sorting nexin 10 | Heel vaak (80–99%) | In 1 aandoening |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Heel vaak (80–99%) | In 1 aandoening |
| TNFRSF1BTNF receptor superfamily member 1B | Heel vaak (80–99%) | In 2 aandoeningen |
| TNFSF11TNF superfamily member 11 | Heel vaak (80–99%) | In 1 aandoening |
| WT1WT1 transcription factor | Heel vaak (80–99%) | In 2 aandoeningen |
| ADA2adenosine deaminase 2 | Vaak (30–79%) | In 1 aandoening |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Vaak (30–79%) | In 1 aandoening |
| AICDAactivation induced cytidine deaminase | Vaak (30–79%) | In 1 aandoening |
| ALKALK receptor tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| ASXL1ASXL transcriptional regulator 1 | Vaak (30–79%) | In 2 aandoeningen |
| BRCA1BRCA1 DNA repair associated | Vaak (30–79%) | In 1 aandoening |
| BRCA2BRCA2 DNA repair associated | Vaak (30–79%) | In 2 aandoeningen |
| CBLCbl proto-oncogene | Vaak (30–79%) | In 1 aandoening |
| CCBE1collagen and calcium binding EGF domains 1 | Vaak (30–79%) | In 1 aandoening |
| CD27CD27 molecule | Vaak (30–79%) | In 1 aandoening |
| CDKN2Acyclin dependent kinase inhibitor 2A | Vaak (30–79%) | In 1 aandoening |
| ELANEelastase, neutrophil expressed | Vaak (30–79%) | In 1 aandoening |
| FAT4FAT atypical cadherin 4 | Vaak (30–79%) | In 1 aandoening |
| FCHO1FCH and mu domain containing endocytic adaptor 1 | Vaak (30–79%) | In 1 aandoening |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Vaak (30–79%) | In 1 aandoening |
| IL6interleukin 6 | Vaak (30–79%) | In 1 aandoening |
| IRAK1interleukin 1 receptor associated kinase 1 | Vaak (30–79%) | In 2 aandoeningen |
| ISG15ISG15 ubiquitin like modifier | Vaak (30–79%) | In 1 aandoening |
| KRASKRas proto-oncogene, GTPase | Vaak (30–79%) | In 1 aandoening |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Vaak (30–79%) | In 1 aandoening |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Vaak (30–79%) | In 1 aandoening |
| LMO1LIM domain only 1 | Vaak (30–79%) | In 1 aandoening |
| MAP2K1mitogen-activated protein kinase kinase 1 | Vaak (30–79%) | In 1 aandoening |
| MIFmacrophage migration inhibitory factor | Vaak (30–79%) | In 1 aandoening |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Vaak (30–79%) | In 1 aandoening |
| NLRP12NLR family pyrin domain containing 12 | Vaak (30–79%) | In 1 aandoening |
| NRASNRAS proto-oncogene, GTPase | Vaak (30–79%) | In 1 aandoening |
| OTULINOTU deubiquitinase with linear linkage specificity | Vaak (30–79%) | In 1 aandoening |
| PALB2partner and localizer of BRCA2 | Vaak (30–79%) | In 1 aandoening |
| PALLDpalladin, cytoskeletal associated protein | Vaak (30–79%) | In 1 aandoening |
| PHOX2Bpaired like homeobox 2B | Vaak (30–79%) | In 1 aandoening |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Vaak (30–79%) | In 2 aandoeningen |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Vaak (30–79%) | In 1 aandoening |
| PRF1perforin 1 | Vaak (30–79%) | In 2 aandoeningen |
| PSMB8proteasome 20S subunit beta 8 | Vaak (30–79%) | In 1 aandoening |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Vaak (30–79%) | In 1 aandoening |
| RAB27ARAB27A, member RAS oncogene family | Vaak (30–79%) | In 1 aandoening |
| RABL3RAB, member of RAS oncogene family like 3 | Vaak (30–79%) | In 1 aandoening |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Vaak (30–79%) | In 1 aandoening |
| RNU4ATACRNA, U4atac small nuclear | Vaak (30–79%) | In 2 aandoeningen |
| RUNX1RUNX family transcription factor 1 | Vaak (30–79%) | In 1 aandoening |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Vaak (30–79%) | In 1 aandoening |
| SMAD4SMAD family member 4 | Vaak (30–79%) | In 1 aandoening |
| SPP1secreted phosphoprotein 1 | Vaak (30–79%) | In 2 aandoeningen |
| SRSF2serine and arginine rich splicing factor 2 | Vaak (30–79%) | In 2 aandoeningen |
| STAT1signal transducer and activator of transcription 1 | Vaak (30–79%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Vaak (30–79%) | In 4 aandoeningen |
| STIM1stromal interaction molecule 1 | Vaak (30–79%) | In 1 aandoening |
| STX11syntaxin 11 | Vaak (30–79%) | In 2 aandoeningen |
| SYKspleen associated tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| TBK1TANK binding kinase 1 | Vaak (30–79%) | In 1 aandoening |
| TLR8toll like receptor 8 | Vaak (30–79%) | In 1 aandoening |
| TNFRSF1ATNF receptor superfamily member 1A | Vaak (30–79%) | In 1 aandoening |
| TP53tumor protein p53 | Vaak (30–79%) | In 1 aandoening |
| TSC1TSC complex subunit 1 | Vaak (30–79%) | In 1 aandoening |
| TSC2TSC complex subunit 2 | Vaak (30–79%) | In 1 aandoening |
| UNC13Dunc-13 homolog D | Vaak (30–79%) | In 1 aandoening |
| WDR1WD repeat domain 1 | Vaak (30–79%) | In 1 aandoening |
| YARS1tyrosyl-tRNA synthetase 1 | Vaak (30–79%) | In 1 aandoening |
| ZNFX1zinc finger NFX1-type containing 1 | Vaak (30–79%) | In 1 aandoening |
| ANKRD55ankyrin repeat domain 55 | Soms (5–29%) | In 1 aandoening |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Soms (5–29%) | In 1 aandoening |
| BAP1BRCA1 associated deubiquitinase 1 | Soms (5–29%) | In 1 aandoening |
| BCL10BCL10 immune signaling adaptor | Soms (5–29%) | In 1 aandoening |
| BCORBCL6 corepressor | Soms (5–29%) | In 1 aandoening |
| BIRC3baculoviral IAP repeat containing 3 | Soms (5–29%) | In 1 aandoening |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Soms (5–29%) | In 1 aandoening |
| BTNL2butyrophilin like 2 | Soms (5–29%) | In 1 aandoening |
| C4Acomplement C4A (Chido/Rodgers blood group) | Soms (5–29%) | In 2 aandoeningen |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Soms (5–29%) | In 1 aandoening |
| CALRcalreticulin | Soms (5–29%) | In 1 aandoening |
| CCR1C-C motif chemokine receptor 1 | Soms (5–29%) | In 1 aandoening |
| CD247CD247 molecule | Soms (5–29%) | In 1 aandoening |
| CR2complement C3d receptor 2 | Soms (5–29%) | In 2 aandoeningen |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Soms (5–29%) | In 1 aandoening |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Soms (5–29%) | In 1 aandoening |
| DLEC1DLEC1 cilia and flagella associated protein | Soms (5–29%) | In 1 aandoening |
| DNASE1deoxyribonuclease 1 | Soms (5–29%) | In 1 aandoening |
| DNASE1L3deoxyribonuclease 1L3 | Soms (5–29%) | In 1 aandoening |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Soms (5–29%) | In 1 aandoening |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Soms (5–29%) | In 1 aandoening |
| ETS1ETS proto-oncogene 1, transcription factor | Soms (5–29%) | In 1 aandoening |
| FCGR2BFc gamma receptor IIb | Soms (5–29%) | In 1 aandoening |
| FCGR3BFc gamma receptor IIIb | Soms (5–29%) | In 1 aandoening |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Soms (5–29%) | In 1 aandoening |
| FOXN1forkhead box N1 | Soms (5–29%) | In 1 aandoening |
| FOXP1forkhead box P1 | Soms (5–29%) | In 1 aandoening |
| FOXP3forkhead box P3 | Soms (5–29%) | In 2 aandoeningen |
| GATA2GATA binding protein 2 | Soms (5–29%) | In 1 aandoening |
| GPC3glypican 3 | Soms (5–29%) | In 1 aandoening |
| H19H19 imprinted maternally expressed transcript | Soms (5–29%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Soms (5–29%) | In 1 aandoening |
| IFNGR1interferon gamma receptor 1 | Soms (5–29%) | In 2 aandoeningen |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Soms (5–29%) | In 1 aandoening |
| IL10interleukin 10 | Soms (5–29%) | In 2 aandoeningen |
| IL12Ainterleukin 12A | Soms (5–29%) | In 1 aandoening |
| IL12A-AS1IL12A antisense RNA 1 | Soms (5–29%) | In 1 aandoening |
| IL23Rinterleukin 23 receptor | Soms (5–29%) | In 1 aandoening |
| IL2RBinterleukin 2 receptor subunit beta | Soms (5–29%) | In 2 aandoeningen |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Soms (5–29%) | In 1 aandoening |
| IRF4interferon regulatory factor 4 | Soms (5–29%) | In 1 aandoening |
| IRF5interferon regulatory factor 5 | Soms (5–29%) | In 1 aandoening |
| ITGAMintegrin subunit alpha M | Soms (5–29%) | In 1 aandoening |
| JAK2Janus kinase 2 | Soms (5–29%) | In 1 aandoening |
| JAZF1JAZF zinc finger 1 | Soms (5–29%) | In 1 aandoening |
| KIAA0319LKIAA0319 like | Soms (5–29%) | In 1 aandoening |
| KITKIT proto-oncogene, receptor tyrosine kinase | Soms (5–29%) | In 2 aandoeningen |
| KLRC4killer cell lectin like receptor C4 | Soms (5–29%) | In 1 aandoening |
| LCATlecithin-cholesterol acyltransferase | Soms (5–29%) | In 1 aandoening |
| LIG4DNA ligase 4 | Soms (5–29%) | In 1 aandoening |
| LRBALPS responsive beige-like anchor protein | Soms (5–29%) | In 1 aandoening |
| LYSTlysosomal trafficking regulator | Soms (5–29%) | In 2 aandoeningen |
| MALT1MALT1 paracaspase | Soms (5–29%) | In 1 aandoening |
| MECP2methyl-CpG binding protein 2 | Soms (5–29%) | In 1 aandoening |
| MEFVMEFV innate immunity regulator, pyrin | Soms (5–29%) | In 2 aandoeningen |
| MPLMPL proto-oncogene, thrombopoietin receptor | Soms (5–29%) | In 1 aandoening |
| MYD88MYD88 innate immune signal transduction adaptor | Soms (5–29%) | In 1 aandoening |
| NABP1nucleic acid binding protein 1 | Soms (5–29%) | In 1 aandoening |
| NOD2nucleotide binding oligomerization domain containing 2 | Soms (5–29%) | In 1 aandoening |
| NPM1nucleophosmin 1 | Soms (5–29%) | In 1 aandoening |
| NUMA1nuclear mitotic apparatus protein 1 | Soms (5–29%) | In 1 aandoening |
| PDCD1programmed cell death 1 | Soms (5–29%) | In 1 aandoening |
| PMLPML nuclear body scaffold | Soms (5–29%) | In 1 aandoening |
| POU6F2POU class 6 homeobox 2 | Soms (5–29%) | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Soms (5–29%) | In 1 aandoening |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Soms (5–29%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Soms (5–29%) | In 2 aandoeningen |
| PXKPX domain containing serine/threonine kinase like | Soms (5–29%) | In 1 aandoening |
| RARAretinoic acid receptor alpha | Soms (5–29%) | In 1 aandoening |
| RESTRE1 silencing transcription factor | Soms (5–29%) | In 1 aandoening |
| RNF6ring finger protein 6 | Soms (5–29%) | In 1 aandoening |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Soms (5–29%) | In 1 aandoening |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Soms (5–29%) | In 1 aandoening |
| SDHCsuccinate dehydrogenase complex subunit C | Soms (5–29%) | In 1 aandoening |
| SOCS1suppressor of cytokine signaling 1 | Soms (5–29%) | In 1 aandoening |
| STAT3signal transducer and activator of transcription 3 | Soms (5–29%) | In 1 aandoening |
| STAT5Bsignal transducer and activator of transcription 5B | Soms (5–29%) | In 1 aandoening |
| TBL1XR1TBL1X/Y related 1 | Soms (5–29%) | In 1 aandoening |
| TGFBR2transforming growth factor beta receptor 2 | Soms (5–29%) | In 1 aandoening |
| TLR4toll like receptor 4 | Soms (5–29%) | In 1 aandoening |
| TLR7toll like receptor 7 | Soms (5–29%) | In 1 aandoening |
| TNFAIP3TNF alpha induced protein 3 | Soms (5–29%) | In 1 aandoening |
| TNFSF4TNF superfamily member 4 | Soms (5–29%) | In 1 aandoening |
| TNIP1TNFAIP3 interacting protein 1 | Soms (5–29%) | In 1 aandoening |
| TREX1three prime repair exonuclease 1 | Soms (5–29%) | In 1 aandoening |
| TRIM28tripartite motif containing 28 | Soms (5–29%) | In 1 aandoening |
| TRIP13thyroid hormone receptor interactor 13 | Soms (5–29%) | In 1 aandoening |
| UBAC2UBA domain containing 2 | Soms (5–29%) | In 1 aandoening |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Soms (5–29%) | In 1 aandoening |
| WWOXWW domain containing oxidoreductase | Soms (5–29%) | In 1 aandoening |
| ZBTB16zinc finger and BTB domain containing 16 | Soms (5–29%) | In 1 aandoening |
| ASAH1N-acylsphingosine amidohydrolase 1 | Zelden (1–4%) | In 1 aandoening |
| COL1A1collagen type I alpha 1 chain | Zelden (1–4%) | In 1 aandoening |
| PDGFBplatelet derived growth factor subunit B | Zelden (1–4%) | In 1 aandoening |
| ACP5acid phosphatase 5, tartrate resistant | Niet vastgelegd | In 1 aandoening |
| ARPC1Bactin related protein 2/3 complex subunit 1B | Niet vastgelegd | In 1 aandoening |
| CARD9caspase recruitment domain family member 9 | Niet vastgelegd | In 1 aandoening |
| CD19CD19 molecule | Niet vastgelegd | In 1 aandoening |
| CYBAcytochrome b-245 alpha chain | Niet vastgelegd | In 1 aandoening |
| CYBBcytochrome b-245 beta chain | Niet vastgelegd | In 1 aandoening |
| ICOSinducible T cell costimulator | Niet vastgelegd | In 2 aandoeningen |
| MCM4minichromosome maintenance complex component 4 | Niet vastgelegd | In 1 aandoening |
| NCF1neutrophil cytosolic factor 1 | Niet vastgelegd | In 1 aandoening |
| NCF2neutrophil cytosolic factor 2 | Niet vastgelegd | In 1 aandoening |
| POMPproteasome maturation protein | Niet vastgelegd | In 1 aandoening |
| PSMB4proteasome 20S subunit beta 4 | Niet vastgelegd | In 1 aandoening |
| SH2D1ASH2 domain containing 1A | Niet vastgelegd | In 1 aandoening |
| SMPD1sphingomyelin phosphodiesterase 1 | Niet vastgelegd | In 1 aandoening |
| TNFRSF13BTNF receptor superfamily member 13B | Niet vastgelegd | In 1 aandoening |
| TNFRSF13CTNF receptor superfamily member 13C | Niet vastgelegd | In 1 aandoening |
| XIAPX-linked inhibitor of apoptosis | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
- Swollen lymph nodes in center of chest36 genen
- Follicular hyperplasia16 genen
- Generalized swelling of lymph nodes14 genen
- Swollen lymph nodes in the neck14 genen
- Chronic noninfectious lymphadenopathy9 genen
- Axillary lymphadenopathy6 genen
- Inguinal lymphadenopathy6 genen
- Hilar lymph node enlargement1 gen
- Paratracheal lymphadenopathy1 gen
- Submandibular lymph node enlargement1 gen
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Voor wie we er zijnOnze wetenschapProductenResultaten
InloggenVraagAan de slagvanaf $ 449
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken